These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 26337818

  • 1. Sildenafil for the Treatment of Congenital Nephrogenic Diabetes Insipidus.
    Assadi F, Sharbaf FG.
    Am J Nephrol; 2015; 42(1):65-9. PubMed ID: 26337818
    [Abstract] [Full Text] [Related]

  • 2. Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride.
    Bedford JJ, Weggery S, Ellis G, McDonald FJ, Joyce PR, Leader JP, Walker RJ.
    Clin J Am Soc Nephrol; 2008 Sep; 3(5):1324-31. PubMed ID: 18596116
    [Abstract] [Full Text] [Related]

  • 3. Effect of the cGMP pathway on AQP2 expression and translocation: potential implications for nephrogenic diabetes insipidus.
    Boone M, Kortenoeven M, Robben JH, Deen PM.
    Nephrol Dial Transplant; 2010 Jan; 25(1):48-54. PubMed ID: 19666909
    [Abstract] [Full Text] [Related]

  • 4. Stimulation of AQP2 membrane insertion in renal epithelial cells in vitro and in vivo by the cGMP phosphodiesterase inhibitor sildenafil citrate (Viagra).
    Bouley R, Pastor-Soler N, Cohen O, McLaughlin M, Breton S, Brown D.
    Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1103-12. PubMed ID: 15644488
    [Abstract] [Full Text] [Related]

  • 5. Physiological insights into novel therapies for nephrogenic diabetes insipidus.
    Sands JM, Klein JD.
    Am J Physiol Renal Physiol; 2016 Dec 01; 311(6):F1149-F1152. PubMed ID: 27534996
    [Abstract] [Full Text] [Related]

  • 6. Sildenafil reduces polyuria in rats with lithium-induced NDI.
    Sanches TR, Volpini RA, Massola Shimizu MH, Bragança AC, Oshiro-Monreal F, Seguro AC, Andrade L.
    Am J Physiol Renal Physiol; 2012 Jan 01; 302(1):F216-25. PubMed ID: 22031848
    [Abstract] [Full Text] [Related]

  • 7. Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration.
    Wilting I, Baumgarten R, Movig KL, van Laarhoven J, Apperloo AJ, Nolen WA, Heerdink ER, Knoers NV, Egberts AC.
    Eur J Pharmacol; 2007 Jul 02; 566(1-3):50-7. PubMed ID: 17466972
    [Abstract] [Full Text] [Related]

  • 8. Activation of AQP2 water channels without vasopressin: therapeutic strategies for congenital nephrogenic diabetes insipidus.
    Ando F, Uchida S.
    Clin Exp Nephrol; 2018 Jun 02; 22(3):501-507. PubMed ID: 29478202
    [Abstract] [Full Text] [Related]

  • 9. Lithium-induced NDI: acetazolamide reduces polyuria but does not improve urine concentrating ability.
    de Groot T, Doornebal J, Christensen BM, Cockx S, Sinke AP, Baumgarten R, Bedford JJ, Walker RJ, Wetzels JFM, Deen PMT.
    Am J Physiol Renal Physiol; 2017 Sep 01; 313(3):F669-F676. PubMed ID: 28615247
    [Abstract] [Full Text] [Related]

  • 10. Amelioration of polyuria in nephrogenic diabetes insipidus due to aquaporin-2 deficiency.
    Hochberg Z, Even L, Danon A.
    Clin Endocrinol (Oxf); 1998 Jul 01; 49(1):39-44. PubMed ID: 9797845
    [Abstract] [Full Text] [Related]

  • 11. Hydrochlorothiazide attenuates lithium-induced nephrogenic diabetes insipidus independently of the sodium-chloride cotransporter.
    Sinke AP, Kortenoeven ML, de Groot T, Baumgarten R, Devuyst O, Wetzels JF, Loffing J, Deen PM.
    Am J Physiol Renal Physiol; 2014 Mar 01; 306(5):F525-33. PubMed ID: 24352504
    [Abstract] [Full Text] [Related]

  • 12. Pathogenesis and treatment of autosomal-dominant nephrogenic diabetes insipidus caused by an aquaporin 2 mutation.
    Sohara E, Rai T, Yang SS, Uchida K, Nitta K, Horita S, Ohno M, Harada A, Sasaki S, Uchida S.
    Proc Natl Acad Sci U S A; 2006 Sep 19; 103(38):14217-22. PubMed ID: 16968783
    [Abstract] [Full Text] [Related]

  • 13. Cooperative mechanisms of acute antidiuretic response to bendroflumethiazide in rats with lithium-induced nephrogenic diabetes insipidus.
    Moosavi SM, Haghani M.
    Can J Physiol Pharmacol; 2010 Dec 19; 88(12):1191-201. PubMed ID: 21164566
    [Abstract] [Full Text] [Related]

  • 14. Combination of secretin and fluvastatin ameliorates the polyuria associated with X-linked nephrogenic diabetes insipidus in mice.
    Procino G, Milano S, Carmosino M, Barbieri C, Nicoletti MC, Li JH, Wess J, Svelto M.
    Kidney Int; 2014 Jul 19; 86(1):127-38. PubMed ID: 24522493
    [Abstract] [Full Text] [Related]

  • 15. Treating lithium-induced nephrogenic diabetes insipidus with a COX-2 inhibitor improves polyuria via upregulation of AQP2 and NKCC2.
    Kim GH, Choi NW, Jung JY, Song JH, Lee CH, Kang CM, Knepper MA.
    Am J Physiol Renal Physiol; 2008 Apr 19; 294(4):F702-9. PubMed ID: 18216147
    [Abstract] [Full Text] [Related]

  • 16. Mouse model of inducible nephrogenic diabetes insipidus produced by floxed aquaporin-2 gene deletion.
    Yang B, Zhao D, Qian L, Verkman AS.
    Am J Physiol Renal Physiol; 2006 Aug 19; 291(2):F465-72. PubMed ID: 16434568
    [Abstract] [Full Text] [Related]

  • 17. Integrin-linked kinase regulates tubular aquaporin-2 content and intracellular location: a link between the extracellular matrix and water reabsorption.
    Cano-Peñalver JL, Griera M, Serrano I, Rodríguez-Puyol D, Dedhar S, de Frutos S, Rodríguez-Puyol M.
    FASEB J; 2014 Aug 19; 28(8):3645-59. PubMed ID: 24784577
    [Abstract] [Full Text] [Related]

  • 18. Effects of sildenafil, metformin, and simvastatin on ADH-independent urine concentration in healthy volunteers.
    Bech AP, Wetzels JFM, Nijenhuis T.
    Physiol Rep; 2018 Apr 19; 6(7):e13665. PubMed ID: 29611351
    [Abstract] [Full Text] [Related]

  • 19. V2R mutations and nephrogenic diabetes insipidus.
    Bichet DG.
    Prog Mol Biol Transl Sci; 2009 Apr 19; 89():15-29. PubMed ID: 20374732
    [Abstract] [Full Text] [Related]

  • 20. A mini-review of pharmacological strategies used to ameliorate polyuria associated with X-linked nephrogenic diabetes insipidus.
    Mortensen LA, Bistrup C, Jensen BL, Hinrichs GR.
    Am J Physiol Renal Physiol; 2020 Nov 01; 319(5):F746-F753. PubMed ID: 32924547
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.